Skip to main content
. Author manuscript; available in PMC: 2014 Sep 13.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008041. doi: 10.1002/14651858.CD008041.pub2
Methods Multicentre, randomised, double-blind, three parallel groups. Single oral dose per attack. Two attacks treated
Medication taken when migraine headache pain of moderate or severe intensity
Assessments at 0 and 2 hours.
If pain not controlled, participants asked to wait 2 hours before taking rescue medication
Participants Aged 18-65 years, meeting IHS criteria for migraine with or without aura. At least 12-month history of migraine, with two to six attacks per month during three months prior to study
N = 421 (385 experienced ≥1 attack and analysed for efficacy)
M = 94, F = 327
Mean age = 39 years
Interventions Lysine acetylsalicylate 1620 mg (equivalent to 900 mg aspirin) plus metoclopramide 10 mg, n = 137
Sumatriptan 100 mg, n = 122
Placebo, n = 126
Outcomes Headache relief at 2 hours
PI: 4-point scale
Pain-free at 2 hours
24-hour sustained relief
Headache recurrence at 24 hours
Relief of nausea and vomiting
Use of rescue medication
PGE: 4-point scale
Adverse effects
Notes Oxford Quality Score: R1, DB2, W1. Total = 4.
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Not described
Allocation concealment? Unclear Not described
Blinding?
All outcomes
Yes Double dummy design